Beta 2 microglobulin expression in keratoacanthomas and squamous cell carcinoma

The British Journal of Dermatology
R GrahamJ R Nash

Abstract

The cell surface expression of beta-2-microglobulin (beta 2 M) was investigated in 33 keratoacanthomas (KA) and 58 squamous cell carcinomas (SCC) to determine whether this antigen was expressed to a different extent in these two conditions and, thus, whether this constitutes a reliable and practical test for distinguishing them. Loss of beta 2 M expression was not a reliable feature for distinguishing between KA and SCC and seemed to be related more to the degree of cellular differentiation and maturation, than to malignancy as such.

References

Jan 1, 1979·The British Journal of Dermatology·A Rook, I Whimster
May 1, 1985·Journal of Surgical Oncology·D P SarmaL E Millikan
Jul 1, 1966·Plastic and Reconstructive Surgery·A G Middleton, J W Curtin
May 1, 1981·The British Journal of Dermatology·M L Turbitt, R M Mackie
May 1, 1981·The British Journal of Dermatology·H R Vinninghe, H A Neumann

Related Concepts

Surface Antigens
Beta-2 Microglobulin
Squamous Cell Carcinoma
Keratoacanthoma
Malignant Neoplasm of Skin

Related Feeds

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.